SCHEMBL30764747

SCHEMBL30764747

CC(C)(C)OC(=O)N1CC2(CN(C(=O)NCc3ccc(F)cc3)C2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC2 Q92769 2/20 0.48
HDAC1 Q13547 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
KIT P10721 1/20 0.47
TP53 P04637 2/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.44
CYP2C19 P33261 1/20 0.44
PKM P14618 1/20 0.44
PARP1 P09874 1/20 0.44
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
DNMT3A Q9Y6K1 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15504601 0.86 TP53 (0.55) MEN1KMT2ANPC1KITTP53
SCHEMBL27253377 0.81 RORC (0.56) HDAC2HDAC1PARP1
SCHEMBL30764709 0.81 HSD11B1 (0.53) HDAC2HDAC1MEN1KMT2AALDH1A1
SCHEMBL17606049 0.81 DNMT3A (0.45) HDAC2HDAC1MEN1KMT2ATP53
SCHEMBL17605822 0.81 DNMT3A (0.44) HDAC2HDAC1MEN1KMT2ATP53
SCHEMBL27253419 0.77 MEN1 (0.54) MEN1KMT2ANPC1KITTP53
SCHEMBL14471738 0.77 GPR119 (0.46) HDAC2HDAC1MEN1KMT2AALDH1A1
SCHEMBL17604866 0.76 RORC (0.43) HDAC2HDAC1MEN1KMT2ATP53
SCHEMBL14892632 0.75 EPHX2 (0.64) ALDH1A1
SCHEMBL32660745 0.75 MAPT (0.64) MEN1KMT2ANPC1KITSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed